Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Antifungal Drug market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 12.0% during the forecast period.
This report presents the market size and development trends by detailing the Antifungal Drug market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Antifungal Drug market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Antifungal Drug industry and will help you to build a panoramic view of the industrial development.
Antifungal Drug Market, By Type:
Echinocandins
Azoles
Ployenes
Allylamines
Others
Antifungal Drug Market, By Application:
Aspergillosis
Dermatophytosis
Candidiasis
Others
Some of the leading players are as follows:
Bayer Healthcare
Gilead
Abbott Laboratories
Novartis
Merck & Co
Sanofi-Aventis
Glaxosmithkline
Kramer Laboratories
Enzon Pharmaceuticals
Pfizer
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Antifungal Drug Market: Technology Type Analysis
-
4.1 Antifungal Drug Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Antifungal Drug Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Echinocandins
4.3.2 Azoles
4.3.3 Ployenes
4.3.4 Allylamines
4.3.5 Others
5 Antifungal Drug Market: Product Analysis
-
5.1 Antifungal Drug Product Market Share Analysis, 2018 & 2026
-
5.2 Antifungal Drug Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Antifungal Drug Market: Application Analysis
-
6.1 Antifungal Drug Application Market Share Analysis, 2018 & 2026
-
6.2 Antifungal Drug Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Aspergillosis
6.3.2 Dermatophytosis
6.3.3 Candidiasis
6.3.4 Others
7 Antifungal Drug Market: Regional Analysis
-
7.1 Antifungal Drug Regional Market Share Analysis, 2018 & 2026
-
7.2 Antifungal Drug Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Bayer Healthcare
9.1.1 Bayer Healthcare Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Gilead
9.2.1 Gilead Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Abbott Laboratories
9.3.1 Abbott Laboratories Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Novartis
9.4.1 Novartis Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Merck & Co
9.5.1 Merck & Co Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Sanofi-Aventis
9.6.1 Sanofi-Aventis Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Glaxosmithkline
9.7.1 Glaxosmithkline Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Kramer Laboratories
9.8.1 Kramer Laboratories Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Enzon Pharmaceuticals
9.9.1 Enzon Pharmaceuticals Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Pfizer
9.10.1 Pfizer Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
The List of Tables and Figures (Totals 71 Figures and 124 Tables)
Figure Echinocandins Antifungal Drug market, 2015 - 2026 (USD Million)
Figure Azoles Antifungal Drug market, 2015 - 2026 (USD Million)
Figure Ployenes Antifungal Drug market, 2015 - 2026 (USD Million)
Figure Allylamines Antifungal Drug market, 2015 - 2026 (USD Million)
Figure Others Antifungal Drug market, 2015 - 2026 (USD Million)
Figure Aspergillosis market, 2015 - 2026 (USD Million)
Figure Dermatophytosis market, 2015 - 2026 (USD Million)
Figure Candidiasis market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Antifungal Drug market, by country, 2015 - 2026 (USD Million)
-
Table North America Antifungal Drug market, by type, 2015 - 2026 (USD Million)
-
Table North America Antifungal Drug market, by product, 2015 - 2026 (USD Million)
-
Table North America Antifungal Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Antifungal Drug market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Antifungal Drug market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Antifungal Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Antifungal Drug market, by type, 2015 - 2026 (USD Million)
-
Table Canada Antifungal Drug market, by product, 2015 - 2026 (USD Million)
-
Table Canada Antifungal Drug market, by application, 2015 - 2026 (USD Million)
-
Table Europe Antifungal Drug market, by country, 2015 - 2026 (USD Million)
-
Table Europe Antifungal Drug market, by type, 2015 - 2026 (USD Million)
-
Table Europe Antifungal Drug market, by product, 2015 - 2026 (USD Million)
-
Table Europe Antifungal Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Antifungal Drug market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Antifungal Drug market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Antifungal Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Antifungal Drug market, by type, 2015 - 2026 (USD Million)
-
Table Germany Antifungal Drug market, by product, 2015 - 2026 (USD Million)
-
Table Germany Antifungal Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Antifungal Drug market, by type, 2015 - 2026 (USD Million)
-
Table France Antifungal Drug market, by product, 2015 - 2026 (USD Million)
-
Table France Antifungal Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Antifungal Drug market, by type, 2015 - 2026 (USD Million)
-
Table Italy Antifungal Drug market, by product, 2015 - 2026 (USD Million)
-
Table Italy Antifungal Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Antifungal Drug market, by type, 2015 - 2026 (USD Million)
-
Table Spain Antifungal Drug market, by product, 2015 - 2026 (USD Million)
-
Table Spain Antifungal Drug market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Antifungal Drug market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Antifungal Drug market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Antifungal Drug market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Antifungal Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Antifungal Drug market, by type, 2015 - 2026 (USD Million)
-
Table China Antifungal Drug market, by product, 2015 - 2026 (USD Million)
-
Table China Antifungal Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Antifungal Drug market, by type, 2015 - 2026 (USD Million)
-
Table Japan Antifungal Drug market, by product, 2015 - 2026 (USD Million)
-
Table Japan Antifungal Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Antifungal Drug market, by type, 2015 - 2026 (USD Million)
-
Table India Antifungal Drug market, by product, 2015 - 2026 (USD Million)
-
Table India Antifungal Drug market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Antifungal Drug market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Antifungal Drug market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Antifungal Drug market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Antifungal Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Antifungal Drug market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Antifungal Drug market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Antifungal Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Antifungal Drug market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Antifungal Drug market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Antifungal Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Antifungal Drug market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Antifungal Drug market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Antifungal Drug market, by application, 2015 - 2026 (USD Million)
-
Table MEA Antifungal Drug market, by country, 2015 - 2026 (USD Million)
-
Table MEA Antifungal Drug market, by type, 2015 - 2026 (USD Million)
-
Table MEA Antifungal Drug market, by product, 2015 - 2026 (USD Million)
-
Table MEA Antifungal Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Antifungal Drug market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Antifungal Drug market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Antifungal Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Antifungal Drug market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Antifungal Drug market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Antifungal Drug market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Bayer Healthcare Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Gilead Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Abbott Laboratories Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Merck & Co Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sanofi-Aventis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Glaxosmithkline Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Kramer Laboratories Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Enzon Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pfizer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
